OBJECTIVES: To determine whether higher cystatin C would be associated with greater frailty in men aged 65 and older. DESIGN: Cross-sectional cohort study. SETTING: Six U.S. sites. PARTICIPANTS: A random sample of community-dwelling men aged 65 and older enrolled in the Osteoporotic Fractures in Men (MrOS) Study (mean age 73.8; 9.8% frail and 47.2% intermediate frailty; N = 1,602). MEASUREMENTS: Serum cystatin C, creatinine, and frailty were measured. Frailty was analyzed as an ordinal outcome of robust, intermediate frailty, and frail using a multinomial logistic regression model, and the base model was adjusted for age, race, and clinical site. RESULTS: Higher cystatin C was associated with seven times greater odds of being frail than being robust (odds ratio (OR) quartile 4 vs 1 = 7.12, 95% confidence interval (CI) = 3.76-13.46) and 2.4 times greater odds of intermediate frailty than robust (OR quartile 4 vs 1 = 2.38, 95% CI = 1.70-3.32). The association was attenuated but persisted after adjusting for multiple possible confounders. In contrast, neither higher serum creatinine (OR quartile 4 vs 1 = 1.36, 95% CI = 0.78-2.40) nor lower creatinine-based estimated glomerular filtration rate (OR quartile 4 vs 1 = 1.01, 95% CI = 0.54-1.87) was associated in a graded manner with greater odds of frailty. CONCLUSION: Higher cystatin C, but not creatinine-based measures, was associated with greater odds of frailty in this cohort of older men.
OBJECTIVES: To determine whether higher cystatin C would be associated with greater frailty in men aged 65 and older. DESIGN: Cross-sectional cohort study. SETTING: Six U.S. sites. PARTICIPANTS: A random sample of community-dwelling men aged 65 and older enrolled in the Osteoporotic Fractures in Men (MrOS) Study (mean age 73.8; 9.8% frail and 47.2% intermediate frailty; N = 1,602). MEASUREMENTS: Serum cystatin C, creatinine, and frailty were measured. Frailty was analyzed as an ordinal outcome of robust, intermediate frailty, and frail using a multinomial logistic regression model, and the base model was adjusted for age, race, and clinical site. RESULTS: Higher cystatin C was associated with seven times greater odds of being frail than being robust (odds ratio (OR) quartile 4 vs 1 = 7.12, 95% confidence interval (CI) = 3.76-13.46) and 2.4 times greater odds of intermediate frailty than robust (OR quartile 4 vs 1 = 2.38, 95% CI = 1.70-3.32). The association was attenuated but persisted after adjusting for multiple possible confounders. In contrast, neither higher serum creatinine (OR quartile 4 vs 1 = 1.36, 95% CI = 0.78-2.40) nor lower creatinine-based estimated glomerular filtration rate (OR quartile 4 vs 1 = 1.01, 95% CI = 0.54-1.87) was associated in a graded manner with greater odds of frailty. CONCLUSION: Higher cystatin C, but not creatinine-based measures, was associated with greater odds of frailty in this cohort of older men.
Authors: Eric Orwoll; Janet Babich Blank; Elizabeth Barrett-Connor; Jane Cauley; Steven Cummings; Kristine Ensrud; Cora Lewis; Peggy M Cawthon; Robert Marcus; Lynn M Marshall; Joan McGowan; Kathy Phipps; Sherry Sherman; Marcia L Stefanick; Katie Stone Journal: Contemp Clin Trials Date: 2005-10 Impact factor: 2.226
Authors: L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie Journal: J Gerontol A Biol Sci Med Sci Date: 2001-03 Impact factor: 6.053
Authors: Linda F Fried; Jung Sun Lee; Michael Shlipak; Glenn M Chertow; Christie Green; Jingzhong Ding; Tamara Harris; Anne B Newman Journal: J Am Geriatr Soc Date: 2006-05 Impact factor: 5.562
Authors: Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh Journal: Ann Intern Med Date: 2009-05-05 Impact factor: 25.391
Authors: Mark J Sarnak; Ronit Katz; Linda F Fried; David Siscovick; Brian Kestenbaum; Stephen Seliger; Dena Rifkin; Russell Tracy; Anne B Newman; Michael G Shlipak Journal: Arch Intern Med Date: 2008-01-28
Authors: Natalie Daya; Annie Voskertchian; Andrea L C Schneider; Shoshana Ballew; Mara McAdams DeMarco; Josef Coresh; Lawrence J Appel; Elizabeth Selvin; Morgan E Grams Journal: Am J Kidney Dis Date: 2015-08-04 Impact factor: 8.860
Authors: Alyson M Cavanaugh; Andrea Z LaCroix; Donna Kritz-Silverstein; Eileen Rillamas-Sun; Dena E Rifkin Journal: J Am Geriatr Soc Date: 2016-09-21 Impact factor: 5.562
Authors: Shu Jin Tan; Matthew Cockcroft; Sam Salman; Laurens Manning; Madhu Page-Sharp; Glenn Arendts; Timothy M E Davis; Brioni R Moore; Kevin T Batty Journal: Antimicrob Agents Chemother Date: 2020-09-21 Impact factor: 5.191
Authors: Allyson Hart; Terri L Blackwell; Misti L Paudel; Brent C Taylor; Eric S Orwoll; Peggy M Cawthon; Kristine E Ensrud Journal: J Gerontol A Biol Sci Med Sci Date: 2017-07-01 Impact factor: 6.053
Authors: Rasheeda K Hall; Jacob B Blumenthal; Rebecca M Doerfler; Jing Chen; Clarissa J Diamantidis; Bernard G Jaar; John W Kusek; Krishna Kallem; Mary B Leonard; Sankar D Navaneethan; Daohang Sha; James H Sondheimer; Lee-Ann Wagner; Wei Yang; Min Zhan; Jeffrey C Fink Journal: Am J Kidney Dis Date: 2021-05-23 Impact factor: 11.072
Authors: Debbie C Chen; Michael G Shlipak; Rebecca Scherzer; Scott R Bauer; O Alison Potok; Dena E Rifkin; Joachim H Ix; Anthony N Muiru; Chi-Yuan Hsu; Michelle M Estrella Journal: JAMA Netw Open Date: 2022-02-01